Lanoteplase
Alternative Names: BMS 200980; FEX 1; nPA; Oneplas; SUN 9216Latest Information Update: 18 Jun 2002
At a glance
- Originator Wyeth
- Class Plasminogen activator enzymes; Thrombolytics
- Mechanism of Action Plasminogen activators; Plasminogen replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Ischaemic heart disorders; Myocardial infarction; Thrombosis
Most Recent Events
- 18 Jun 2002 Discontinued - Preregistration for Myocardial infarction in Japan (Injection)
- 26 Mar 2002 American Home Products and its subsidiary Wyeth-Ayerst are both now called Wyeth
- 23 Jan 2001 Discontinued-III for Ischaemic heart disorders in USA (Injection)